Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells

PLoS One. 2013 Oct 8;8(10):e77157. doi: 10.1371/journal.pone.0077157. eCollection 2013.

Abstract

Cellular senescence is an irreversible state of proliferation arrest evoked by a myriad of stresses including oncogene activation, telomere shortening/dysfunction and genotoxic insults. It has been associated with tumor activation, immune suppression and aging, owing to the secretion of proinflammatory mediators. The bacterial genotoxin colibactin, encoded by the pks genomic island is frequently harboured by Escherichia coli strains of the B2 phylogenetic group. Mammalian cells exposed to live pks+ bacteria exhibit DNA-double strand breaks (DSB) and undergo cell-cycle arrest and death. Here we show that cells that survive the acute bacterial infection with pks+ E. coli display hallmarks of cellular senescence: chronic DSB, prolonged cell-cycle arrest, enhanced senescence-associated β-galactosidase (SA-β-Gal) activity, expansion of promyelocytic leukemia nuclear foci and senescence-associated heterochromatin foci. This was accompanied by reactive oxygen species production and pro-inflammatory cytokines, chemokines and proteases secretion. These mediators were able to trigger DSB and enhanced SA-β-Gal activity in bystander recipient cells treated with conditioned medium from senescent cells. Furthermore, these senescent cells promoted the growth of human tumor cells. In conclusion, the present data demonstrated that the E. coli genotoxin colibactin induces cellular senescence and subsequently propel bystander genotoxic and oncogenic effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Checkpoints
  • Cell Line
  • Cellular Senescence*
  • DNA Damage
  • Epithelial Cells / microbiology
  • Epithelial Cells / pathology
  • Escherichia coli / physiology*
  • Escherichia coli Infections / genetics
  • Escherichia coli Infections / metabolism
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Infections / pathology*
  • Fibroblasts / microbiology
  • Fibroblasts / pathology
  • Gene Expression Regulation
  • Host-Pathogen Interactions*
  • Humans
  • Peptides / genetics
  • Peptides / metabolism*
  • Polyketides / metabolism*
  • Rats
  • beta-Galactosidase / genetics

Substances

  • Peptides
  • Polyketides
  • colibactin
  • beta-Galactosidase

Grants and funding

This work was made possible by financial support SFI20101201751 from the French fondation ARC pour la recherche sur le cancer, by the Agence Nationale de la Recherche (ANR-10-CESA-0011) and grant AO-blanc-2010 from INRA. Thomas Secher was supported by the Agence Nationale de la Recherche (ANR-09-MIE-005) and by the conseil régional de Midi-Pyrénées (12050986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.